The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets. FDA launches AI tool Elsa | Drug ...

The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside ...

FDA rushed out agency-wide AI tool—it’s not going well An agency-wide LLM called Elsa was released weeks ahead of schedule.

FDA claims victory with "Elsa" AI tool launch, but insiders call it half-baked Employees say FDA's Elsa launch prioritized optics over usability By Cal Jeffrey June 5, 2025, 13:39.

The U.S. Food and Drug Administration (“FDA”) has fast-tracked the rollout of its AI tool, Elsa, originally planned for June 30, with Commissioner Dr Tuesday, 02 January 2024 12:17 GMT عربي ...

FDA Commissioner Dr Marty Makary. The FDA is moving at breakneck speed to roll out a generative artificial intelligence (AI) tool for speeding up regulatory reviews, announcing its launch nearly a ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. The FDA plans to roll out its new AI tool, called Elsa ...

The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, several weeks ahead of its original schedule.

Elsa’s launch also came on the heels of Trump’s 2026 budget proposal (PDF), which recommends cutting the FDA’s budget by 4%, including the cutting of 1,940 staff salaries.

It said Elsa is a large language model-powered AI tool built within a “high-security GovCloud environment.” The FDA said the tool will assist with reading, writing and summarizing information.